Nearly half of patients with treatment-resistant epilepsy were seizure free at one year with Keppra-only therapy, according to a real-life retrospective audit presented at the 9th European Congress on Epileptology. Keppra, a brand name drug available in generic forms under the name levetiracetam, is an FDA-approved anti-seizure drug used to treat seizures in epileptics and traumatic brain injury patients.

The study was a “real-life observational study” rather than a randomized controlled trial and involved 228 patients. The dose most often prescribed for patients newly diagnosed as having refractory epilepsy is 1000 mg/day. At baseline, approximately 60 percent of patients in the study had experienced fewer than five seizures and 40 percent had had more than five seizures. Two-thirds of the patients involved in the study took levetiracetam as their first antiepileptic drug, and another one-third were switched from a different drug to levetiracetam. More than half of the patients were prescribed 250 mg twice daily for two weeks, and then the dose was increased to 500 mg twice daily. Overall, 49 percent of patients who received the drug were seizure free for more than a year.

The study did not review patients who had switched from brand name Keppra to a generic version of the drug. Some studies indicate that the subtle differences in the inactive ingredients between Keppra and generics can trigger seizures that were previously controlled.

Dr. Martin Brodie, director of the Epilepsy Unit, Western Infirmary, Glasgow, United Kingdom, the medical doctor who presented the Keppra study, said one of the main reasons for the audit was to identify a side effect profile of the drug. Adverse events that removed 16.2 participants from the study included aggression, irritability, mood swings and depression.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Generic drug savings may come at a price

Think generic medications are just the same as their brand name equivalents? Think again. Generics may...

New iPhone app helps epileptics monior seizures,...

People living with epilepsy can now keep a diary of their seizures on their iPhone, thanks to the new...

Switching from Keppra to generic can make you sick

Switching from brand name Keppra to generic Keppra (levetiracetam) to treat her epileptic seizures made...

Experimental SmartWatch offers peace of mind to...

A fully functional prototype of a wristwatch-style device that can detect myoclonic and grand mal...

Free toolkit available to parents of children...

Parents of children diagnosed with epilepsy have the daunting responsibility of helping their child...

Approval of GlaxoSmithKline, Valeant new epilepsy drug...

Despite a "thumbs-up" from a Food and Drug Administration (FDA) advisory panel on GlaxoSmithKline and...

Highly recommended

I would highly recommend this law firm to handle any of your legal needs.

—Sandy